Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who...

|By:, SA News Editor

Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who may have been infected was cancelled by officials after the system became overwhelmed. A former lab technician at a New Hampshire hospital was indicted last week for allegedly infecting 31 people with the virus. Biotech shares that specialize in the field are active: GILD +0.5%, VRTX +1.3%, IDIX +1%.